Institutional Ownership Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY). We have compiled data on the 31 institutions that hold shares in the stock, with a total of 46.8 Million shares, which have been reported (via 13F filing form) to have a value of $32.7 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tandem Capital Management Corp
|
Oct 25, 2024 Q3 2024 |
15,500
shares
|
$10,850
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Creative Planning
Overland Park, KS |
Oct 11, 2024 Q3 2024 |
10,231
shares
|
$7,161
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
332
shares
|
$232
0.0% of portfolio
|
Q3 2024
Added 48.88%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
207
shares
|
$144
0.0% of portfolio
|
Q3 2024
Added 195.71%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
1
shares
|
$0
0.0% of portfolio
|
Q2 2024
Reduced 99.98%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|